Markets

Health Care Sector Update for 10/02/2015: HZNP, HLS, CLRB

Top Health-care stocks:

JNJ: -0.8%

PFE: +0.8%

ABT: -2.4%

MRK: flat

AMGN: -0.6%

Health-care shares were mixed in pre-market trade Friday.

In health-care stocks news, Horizon Pharma ( HZNP ) said its Horizon Pharma Switzerland unit has reached a settlement and license agreement with Actavis Laboratories (ACT) to resolve pending patent litigation involving RAYOS Delayed-Release Tablets for rheumatoid arthritis patients.

Shares in Horizon Pharma were 3.9% lower at $19.56 pre-bell. Over the past 52 weeks, the company has traded between $10.15 and $39.49.

HealthSouth ( HLS ), an owner and operator of in-patient rehabilitation hospitals, late Thursday said it has completed acquiring Reliant Hospital Partners for approximately $730 million in cash.

Shares in the company were unchanged at $36.90 pre-bell. Over the past 52 weeks, the company has traded between $36.38 and $48.37.

And Cellectar Biosciences, Inc. ( CLRB ), a biopharmaceutical company, said Friday that it has closed its registered direct offering of 1 million shares of common stock and series B pre-funded warrants to purchase 482,728 shares of common stock at a price of $2.20 per share.

Shares in the company were unchanged at $1.84 pre-bell. Over the past 52 weeks, the company has traded between $1.76 and $3.89.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

HZNP CLRB

Other Topics

Commodities

Latest Markets Videos